1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
- Contribution to journal › Article
- 2024
-
Mark
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma
- Contribution to journal › Article
- 2015
-
Mark
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.
- Contribution to journal › Article
- 2013
-
Mark
Late divergence of survival curves in cancer immunotherapy trials: interpretation and implications
- Contribution to journal › Article
-
Mark
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
- Contribution to journal › Article
- 2012
-
Mark
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
- Contribution to journal › Article
- 2011
-
Mark
Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer.
- Contribution to journal › Article
- 2009
-
Mark
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
- Contribution to journal › Article
-
Mark
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
- Contribution to journal › Article
- 2000
-
Mark
Immunohistochemical analysis of glioma-infiltrating leucocytes after peripheral therapeutic immunization with interferon-gamma-transfected glioma cells
- Contribution to journal › Article
